Cassady Schiller Wealth Management LLC Sells 64 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cassady Schiller Wealth Management LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,506 shares of the medical equipment provider’s stock after selling 64 shares during the period. Cassady Schiller Wealth Management LLC’s holdings in Intuitive Surgical were worth $508,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its holdings in shares of Intuitive Surgical by 7.3% in the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 736 shares of the medical equipment provider’s stock worth $215,000 after purchasing an additional 50 shares during the period. OVERSEA CHINESE BANKING Corp Ltd raised its holdings in shares of Intuitive Surgical by 55.3% in the 3rd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,126 shares of the medical equipment provider’s stock valued at $329,000 after acquiring an additional 401 shares in the last quarter. US Bancorp DE raised its holdings in shares of Intuitive Surgical by 0.3% in the 3rd quarter. US Bancorp DE now owns 62,039 shares of the medical equipment provider’s stock valued at $18,133,000 after acquiring an additional 186 shares in the last quarter. Signaturefd LLC boosted its position in shares of Intuitive Surgical by 2.7% during the 3rd quarter. Signaturefd LLC now owns 6,151 shares of the medical equipment provider’s stock valued at $1,798,000 after acquiring an additional 162 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 13.0% during the third quarter. EverSource Wealth Advisors LLC now owns 792 shares of the medical equipment provider’s stock worth $231,000 after purchasing an additional 91 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 175 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $387.22, for a total transaction of $67,763.50. Following the sale, the senior vice president now directly owns 533 shares in the company, valued at $206,388.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Mark Brosius sold 175 shares of the business’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $387.22, for a total transaction of $67,763.50. Following the sale, the senior vice president now owns 533 shares of the company’s stock, valued at $206,388.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Marshall Mohr sold 108,790 shares of the business’s stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares in the company, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 148,290 shares of company stock valued at $57,207,154. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $4.03 during trading hours on Thursday, hitting $396.87. The company’s stock had a trading volume of 685,053 shares, compared to its average volume of 1,536,141. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $408.43. The stock has a market cap of $140.77 billion, a price-to-earnings ratio of 72.36, a P/E/G ratio of 5.19 and a beta of 1.39. The business has a 50-day simple moving average of $386.00 and a 200-day simple moving average of $360.92.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period last year, the company earned $1.00 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have commented on ISRG. Barclays boosted their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Mizuho raised their price target on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. BTIG Research upped their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Finally, Royal Bank of Canada upped their target price on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.